MindWalk unveils longevity-focused GLP-1 program

AI-designed ‘companion therapeutic’ works alongside GLP-1 therapy through a complementary mechanism linked to healthy aging. Hot on the heels of multiple references to GLP-1 receptor agonists as longevity drugs at the recent Aging Research and Drug Discovery meeting in Copenhagen, AI-pow…